Pkarmacokinetic and absolute bioavailability of marbofloxacin in buffaloes (Bubalus bubalis).

The aim of this study was to evaluate the pharmacokinetic behaviour and the absolute bioavailability of marbofloxacin (MFX) in adult water buffaloes and to estimate the pharmacokinetic parameters for calculating the therapeutic dose in this animal species. Six adult buffaloes (3 males and 3 females)...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Anadón, A
Formato: Artículo revista
Lenguaje:Español
Publicado: Universidad Nacional del Litoral 2021
Materias:
Acceso en línea:https://bibliotecavirtual.unl.edu.ar/publicaciones/index.php/FAVEveterinaria/article/view/10913
Aporte de:
id I26-R133-article-10913
record_format ojs
spelling I26-R133-article-109132021-12-07T14:23:08Z Pkarmacokinetic and absolute bioavailability of marbofloxacin in buffaloes (Bubalus bubalis). FARMACOCINÉTICA Y BIODISPONIBILIDAD ABSOLUTA DE MARBOFLOXACINA EN BÚFALOS (Bubalus bubalis) Anadón, A Marbofloxacin, Pharmacokinetic, Bioavailabiliy, Buffaloes Marbofloxacina, Farmacocinética, Biodisponibilidad, Búfalos The aim of this study was to evaluate the pharmacokinetic behaviour and the absolute bioavailability of marbofloxacin (MFX) in adult water buffaloes and to estimate the pharmacokinetic parameters for calculating the therapeutic dose in this animal species. Six adult buffaloes (3 males and 3 females) where treated by intravenous (IV) and subcutaneous (SC) route with a 10% experimental MFX injectable formulation at the dose of 2 mg/kg. After administration blood samples were drawn at pre-established times and MFX plasma concentrations where determined by microbiologic method. The pharmacokinetic analysis was made by compartmental analysis. After IV administration MFX presented a clearance of 198.4 ± 21.0 mL.kg.h and a half-life of elimination of 7.64 ± 3.29 h. After SC administration marbofloxacin presented a half-life of elimination of 8.5 ± 2.42 h, reaching it maximum plasma concentration (1.67 ± 0.516 μg/mL) at 1.69 ± 0.231 h, with a bioavailability of 80.8 ± 11.2 %. The estimated values of clearance and bioavailability will be employed in further studies for calculating the therapeutic dose of MFX in water buffaloes.     Universidad Nacional del Litoral 2021-12-02 info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion application/pdf https://bibliotecavirtual.unl.edu.ar/publicaciones/index.php/FAVEveterinaria/article/view/10913 10.14409/favecv.v19isuplemento.10913 FAVE Sección Ciencias Veterinarias; Vol. 19 Núm. suplemento (2021): FAVE Sección Ciencias Veterinarias FAVE Sección Ciencias Veterinarias; Vol. 19 No. suplemento (2021): FAVE Sección Ciencias Veterinarias FAVE Sección Ciencias Veterinarias; v. 19 n. suplemento (2021): FAVE Sección Ciencias Veterinarias 2362-5589 1666-938X 10.14409/favecv.v19isuplemento spa https://bibliotecavirtual.unl.edu.ar/publicaciones/index.php/FAVEveterinaria/article/view/10913/14944
institution Universidad Nacional del Litoral
institution_str I-26
repository_str R-133
container_title_str Biblioteca Virtual - Publicaciones (UNL)
language Español
format Artículo revista
topic Marbofloxacin, Pharmacokinetic, Bioavailabiliy, Buffaloes
Marbofloxacina, Farmacocinética, Biodisponibilidad, Búfalos
spellingShingle Marbofloxacin, Pharmacokinetic, Bioavailabiliy, Buffaloes
Marbofloxacina, Farmacocinética, Biodisponibilidad, Búfalos
Anadón, A
Pkarmacokinetic and absolute bioavailability of marbofloxacin in buffaloes (Bubalus bubalis).
topic_facet Marbofloxacin, Pharmacokinetic, Bioavailabiliy, Buffaloes
Marbofloxacina, Farmacocinética, Biodisponibilidad, Búfalos
author Anadón, A
author_facet Anadón, A
author_sort Anadón, A
title Pkarmacokinetic and absolute bioavailability of marbofloxacin in buffaloes (Bubalus bubalis).
title_short Pkarmacokinetic and absolute bioavailability of marbofloxacin in buffaloes (Bubalus bubalis).
title_full Pkarmacokinetic and absolute bioavailability of marbofloxacin in buffaloes (Bubalus bubalis).
title_fullStr Pkarmacokinetic and absolute bioavailability of marbofloxacin in buffaloes (Bubalus bubalis).
title_full_unstemmed Pkarmacokinetic and absolute bioavailability of marbofloxacin in buffaloes (Bubalus bubalis).
title_sort pkarmacokinetic and absolute bioavailability of marbofloxacin in buffaloes (bubalus bubalis).
description The aim of this study was to evaluate the pharmacokinetic behaviour and the absolute bioavailability of marbofloxacin (MFX) in adult water buffaloes and to estimate the pharmacokinetic parameters for calculating the therapeutic dose in this animal species. Six adult buffaloes (3 males and 3 females) where treated by intravenous (IV) and subcutaneous (SC) route with a 10% experimental MFX injectable formulation at the dose of 2 mg/kg. After administration blood samples were drawn at pre-established times and MFX plasma concentrations where determined by microbiologic method. The pharmacokinetic analysis was made by compartmental analysis. After IV administration MFX presented a clearance of 198.4 ± 21.0 mL.kg.h and a half-life of elimination of 7.64 ± 3.29 h. After SC administration marbofloxacin presented a half-life of elimination of 8.5 ± 2.42 h, reaching it maximum plasma concentration (1.67 ± 0.516 μg/mL) at 1.69 ± 0.231 h, with a bioavailability of 80.8 ± 11.2 %. The estimated values of clearance and bioavailability will be employed in further studies for calculating the therapeutic dose of MFX in water buffaloes.    
publisher Universidad Nacional del Litoral
publishDate 2021
url https://bibliotecavirtual.unl.edu.ar/publicaciones/index.php/FAVEveterinaria/article/view/10913
work_keys_str_mv AT anadona pkarmacokineticandabsolutebioavailabilityofmarbofloxacininbuffaloesbubalusbubalis
AT anadona farmacocineticaybiodisponibilidadabsolutademarbofloxacinaenbufalosbubalusbubalis
first_indexed 2023-07-05T23:06:05Z
last_indexed 2023-07-05T23:06:05Z
_version_ 1770623719631224832